OVID

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Ovid Therapeutics Inc

NASDAQ | OVID

1.24

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 8, 2025)

$87.47M

Market Cap

-

P/E Ratio

-0.54

EPS

$1.47

52 Week High

$0.24

52 Week Low

HEALTHCARE

Sector

OVID Chart

Recent Chart
Price Action

OVID Technicals

Tags:

OVID Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $566K
Total Revenue $566K
Cost Of Revenue $600K
Costof Goods And Services Sold $600K
Operating Income -$62M
Selling General And Administrative $26M
Research And Development $37M
Operating Expenses $62M
Investment Income Net -
Net Interest Income $3.9M
Interest Income $3.9M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $613K
Income Before Tax -$26M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$26M
Comprehensive Income Net Of Tax -
Ebit -$58M
Ebitda -$58M
Net Income -$26M

Revenue & Profitability

Earnings Performance

OVID Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $92M
Total Current Assets $56M
Cash And Cash Equivalents At Carrying Value $26M
Cash And Short Term Investments $26M
Inventory -
Current Net Receivables -
Total Non Current Assets $36M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $92K
Intangible Assets Excluding Goodwill $92K
Goodwill -
Investments -
Long Term Investments $21M
Short Term Investments $27M
Other Current Assets $2.9M
Other Non Current Assets -
Total Liabilities $24M
Total Current Liabilities $11M
Current Accounts Payable $3.2M
Deferred Revenue -
Current Debt -
Short Term Debt $2.7M
Total Non Current Liabilities $13M
Capital Lease Obligations $15M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $15M
Other Current Liabilities $4.7M
Other Non Current Liabilities -
Total Shareholder Equity $68M
Treasury Stock -
Retained Earnings -$304M
Common Stock $71K
Common Stock Shares Outstanding $71M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$56M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $613K
Capital Expenditures $71K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $55M
Cashflow From Financing $622K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$26M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $566K
Total Revenue $566K
Cost Of Revenue $600K
Costof Goods And Services Sold $600K
Operating Income -$62M
Selling General And Administrative $26M
Research And Development $37M
Operating Expenses $62M
Investment Income Net -
Net Interest Income $3.9M
Interest Income $3.9M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $613K
Income Before Tax -$26M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$26M
Comprehensive Income Net Of Tax -
Ebit -$58M
Ebitda -$58M
Net Income -$26M

OVID News

OVID Profile

Ovid Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York.

NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
GNPX
+47.39%
$0.22
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
AAL
-0.99%
$12.95
SNAP
-1.16%
$7.22
NIO
+3.61%
$6.16
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
MARA
+0.06%
$15.20
RAYA
-12.69%
$0.03
DNN
+1.70%
$2.39
KVUE
-0.80%
$18.47
TLRY
-5.88%
$1.12
SOFI
+1.40%
$25.96
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
WBD
+2.10%
$12.36
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
IXHL
-9.48%
$0.52
INTC
-0.04%
$24.48
HL
+12.08%
$10.11
NVVE
+9.46%
$0.24
PFE
-1.24%
$24.57
BAC
-0.58%
$49.48
PLTR
+1.95%
$156.10
LDI
+31.48%
$3.80
BTG
+2.87%
$4.29
YAAS
-21.46%
$0.08
MBOT
+22.95%
$4.50
AAPL
-0.75%
$237.88
ILLR
+22.34%
$0.52
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
MGIH
+42.13%
$2.25
T
-2.33%
$28.90
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
AIRE
+16.00%
$0.47
BMNR
+4.28%
$43.84
AMD
+0.22%
$151.47
RR
+17.78%
$2.98
CPNG
+9.19%
$31.56
BBD
-0.47%
$3.16
HIMS
+2.60%
$49.67
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
AVGO
+3.40%
$346.30
GRAB
+0.58%
$5.19
GOOGL
-0.31%
$234.04
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
WULF
+0.76%
$9.19
HBAN
+0.36%
$17.69
F
-0.59%
$11.67
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
WLGS
-5.57%
$0.04
RIG
+2.93%
$3.16
ADAP
+3.65%
$0.04
KDP
-4.24%
$27.43
CIFR
+2.65%
$7.72
NOK
+0.76%
$4.58
ETWO
0.00%
$3.30
INFY
+2.53%
$16.79
CMG
-4.39%
$39.25
RGTI
+0.33%
$15.15
SATS
+19.91%
$80.63
AFMD
-34.94%
$0.18
BINI
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
VZ
-2.62%
$43.21
CRWV
+5.00%
$93.55
ETHD
+1.96%
$3.63
QBTS
+0.55%
$15.45
JOBY
+0.43%
$13.51
IREN
+0.15%
$26.19
ITUB
-0.56%
$7.06
DVLT
+1.69%
$0.31
GOOG
-0.42%
$234.16
LYFT
+6.30%
$17.71
AG
+3.33%
$9.45
JD
+4.45%
$32.85
TAIT
+64.40%
$3.51
SLB
-0.06%
$35.79
BTE
+0.68%
$2.19
NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
GNPX
+47.39%
$0.22
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
AAL
-0.99%
$12.95
SNAP
-1.16%
$7.22
NIO
+3.61%
$6.16
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
MARA
+0.06%
$15.20
RAYA
-12.69%
$0.03
DNN
+1.70%
$2.39
KVUE
-0.80%
$18.47
TLRY
-5.88%
$1.12
SOFI
+1.40%
$25.96
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
WBD
+2.10%
$12.36
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
IXHL
-9.48%
$0.52
INTC
-0.04%
$24.48
HL
+12.08%
$10.11
NVVE
+9.46%
$0.24
PFE
-1.24%
$24.57
BAC
-0.58%
$49.48
PLTR
+1.95%
$156.10
LDI
+31.48%
$3.80
BTG
+2.87%
$4.29
YAAS
-21.46%
$0.08
MBOT
+22.95%
$4.50
AAPL
-0.75%
$237.88
ILLR
+22.34%
$0.52
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
MGIH
+42.13%
$2.25
T
-2.33%
$28.90
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
AIRE
+16.00%
$0.47
BMNR
+4.28%
$43.84
AMD
+0.22%
$151.47
RR
+17.78%
$2.98
CPNG
+9.19%
$31.56
BBD
-0.47%
$3.16
HIMS
+2.60%
$49.67
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
AVGO
+3.40%
$346.30
GRAB
+0.58%
$5.19
GOOGL
-0.31%
$234.04
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
WULF
+0.76%
$9.19
HBAN
+0.36%
$17.69
F
-0.59%
$11.67
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
WLGS
-5.57%
$0.04
RIG
+2.93%
$3.16
ADAP
+3.65%
$0.04
KDP
-4.24%
$27.43
CIFR
+2.65%
$7.72
NOK
+0.76%
$4.58
ETWO
0.00%
$3.30
INFY
+2.53%
$16.79
CMG
-4.39%
$39.25
RGTI
+0.33%
$15.15
SATS
+19.91%
$80.63
AFMD
-34.94%
$0.18
BINI
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
VZ
-2.62%
$43.21
CRWV
+5.00%
$93.55
ETHD
+1.96%
$3.63
QBTS
+0.55%
$15.45
JOBY
+0.43%
$13.51
IREN
+0.15%
$26.19
ITUB
-0.56%
$7.06
DVLT
+1.69%
$0.31
GOOG
-0.42%
$234.16
LYFT
+6.30%
$17.71
AG
+3.33%
$9.45
JD
+4.45%
$32.85
TAIT
+64.40%
$3.51
SLB
-0.06%
$35.79
BTE
+0.68%
$2.19
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.